NDC 16729-008-17 - PRAVASTATIN SODIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-008
- Requested NDC
- 16729-008-17
- Package NDCs from labels
- 16729-008-15, 16729-008-16, 16729-008-17
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-11-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PRAVASTATIN SODIUM - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-11-14 | HUMAN PRESCRIPTION DRUG LABEL |
| PRAVASTATIN SODIUM - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-14 | HUMAN PRESCRIPTION DRUG LABEL |
| PRAVASTATIN SODIUM - DIRECT RX | DIRECT RX | 2023-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
| PRAVASTATIN SODIUM - A-S Medication Solutions | A-S Medication Solutions | 2023-02-06 | HUMAN PRESCRIPTION DRUG LABEL |
| PRAVASTATIN SODIUM - Bryant Ranch Prepack | Bryant Ranch Prepack | 2022-05-02 | HUMAN PRESCRIPTION DRUG LABEL |
| PRAVASTATIN SODIUM - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-02-12 | HUMAN PRESCRIPTION DRUG LABEL |
| PRAVASTATIN SODIUM - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2019-11-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-008-15 | PRAVASTATIN SODIUM | 90 in 1 BOTTLE | TABLET | 90 | 10 | |
| 16729-008-16 | PRAVASTATIN SODIUM | 500 in 1 BOTTLE | TABLET | 500 | 10 | |
| 16729-008-17 | PRAVASTATIN SODIUM | 1000 in 1 BOTTLE | TABLET | 1000 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-008-15 | EA - Each | 16729-008 | e9a45a59-b3b4-4bc3-abe4-d573bd1d5523 | 1 | 2017-03-06 |
| 16729-008-16 | EA - Each | 16729-008 | 9ed940e9-daa9-4502-bc93-e3dfed19e5c9 | 1 | 2017-03-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Calamine | CALAMINE AND ZINC OXIDE | Pharma Nobis, LLC | fbcfa541-beda-06de-e053-6294a90a9298 | 2026-05-26 | Warnings | 1K09F3G675 |
| Ripple | GLYCERIN, POVIDONE | CorneaCare Inc | 3b5ba197-d501-681e-e063-6294a90aefb5 | 2026-05-24 | Warnings | FZ989GH94E |
| Magnesium Oxide | MAGNESIUM OXIDE | Bryant Ranch Prepack | 9875ae6b-2d91-49a3-9512-60a2b8bbccda | 2026-05-22 | Warnings | 3A3U0GI71G |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | PD-Rx Pharmaceuticals, Inc. | 2ded7e5e-c377-4495-a045-f1c57b90c5db | 2026-05-21 | Warnings, Adverse reactions | ANDA207068 904467 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | PD-Rx Pharmaceuticals, Inc. | 46fdf929-c961-4dd9-8865-8eb4adaa259a | 2026-05-21 | Warnings, Adverse reactions | ANDA207068 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Bryant Ranch Prepack | daacdad5-f75d-4f9f-b623-8071f3bef91e | 2026-05-19 | Warnings, Adverse reactions | ANDA207068 904467 3M8608UQ61 |
| Pravastatin Sodium | PRAVASTATIN SODIUM | Amici Pharma, Inc. | e6551230-fe4c-4a6e-9c19-ae9945b76db0 | 2026-05-19 | Warnings, Adverse reactions | 904458 904481 904467 904475 3M8608UQ61 |
| Calamine Plus Pramoxine HCl | CALAMINE PLUS SPRAY | CVS Pharmacy | db6f518d-3a0e-43f8-8d19-7382d9b7ff1c | 2026-05-11 | Warnings | 1K09F3G675 |
| Calamine | FERRIC OXIDE RED | Retail Business Services, LLC | 7291e175-a9b6-4c47-93ce-227ce11e4599 | 2026-04-30 | Warnings, Adverse reactions | 1K09F3G675 |
| iVIZIA Lubricant Eye Gel | POVIDONE | Thea Pharma Inc. | 1f06ca1a-5270-9a82-e063-6294a90aed64 | 2026-04-29 | Warnings | FZ989GH94E |
| GoodSense Eye Drops Advanced Relief Moisturizer | DEXTRAN, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Preferred PHarmaceuticals Inc. | 011473a8-26d5-4661-b3c0-745f9b6aa1d8 | 2026-04-29 | Warnings | FZ989GH94E |
| Folyra | MULTIVITAMIN | Oncora Pharma, LLC | cb182e26-17c5-4d00-869f-08823afeeee8 | 2026-04-28 | Warnings, Adverse reactions | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Bryant Ranch Prepack | 77fa8fe5-33ac-44b2-9596-5b276e9f2162 | 2026-04-24 | Warnings | 3A3U0GI71G |
| Pravastatin sodium | PRAVASTATIN SODIUM | Golden State Medical Supply, Inc. | 25b7276e-a69f-af63-e063-6394a90aecf2 | 2026-04-21 | Warnings, Adverse reactions | 904458 904481 904467 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | Northwind Health Company, LLC | 4fad5d73-aa79-58f2-e063-6294a90af4aa | 2026-04-16 | Warnings, Adverse reactions | 904458 3M8608UQ61 |
| CLENPIQ | SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID | Ferring Pharmaceuticals Inc. | e95fff66-4ec0-4001-a727-33e66a5ec7d5 | 2026-04-15 | Warnings, Adverse reactions | 3A3U0GI71G |
| PRENATE Enhance | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, FOLIC ACID, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, BIOTIN, CALCIUM CARBONATE, FERROUS FUMARATE, MAGNESIUM OXIDE, LACTIC ACID AND DOCONEXENT | Avion Pharmaceuticals, LLC | cf10de09-6ed5-4a66-84fa-2da4f668bbe6 | 2026-04-14 | Boxed warning, Adverse reactions | 3A3U0GI71G |
| Multitam | FOLIC ACID | PureTek Corporation | cee15842-4a9e-c6ba-e053-2a95a90aebc5 | 2026-04-13 | Warnings, Adverse reactions | 3A3U0GI71G |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | A-S Medication Solutions | 93b0e546-9e0f-40d1-9b1e-082bf16400a4 | 2026-04-13 | Warnings, Adverse reactions | 904467 904475 3M8608UQ61 |
| PRAVASTATIN SODIUM | PRAVASTATIN SODIUM | A-S Medication Solutions | d69e8af8-dbd4-43d9-8e9a-4aed3923a17c | 2026-04-13 | Warnings, Adverse reactions | 904475 3M8608UQ61 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.